TOS.TO - TSO3 Inc.

Toronto - Toronto Delayed Price. Currency in CAD

TSO3 Inc.

2505, Avenue Dalton
Quebec, QC G1P 3S5

IndustryMedical Instruments & Supplies
Full Time Employees73

Key Executives

Mr. Richard M. RumbleChief Exec. Officer, Pres and Director630.72kN/A58
Mr. Glen Kayll MBA, CAChief Financial Officer368.83kN/A48
Mr. Harold R. TessmanChief Operating Officer277.67kN/AN/A
Mr. James Ralph MillsVP of HR82.89kN/AN/A
Mr. Anan NatarajanSr. VP of Global Commercialization36.39kN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices. The company’s principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. It also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes; and STERIZONE CI+ chemical indicator in Canada. In addition, the company develops bottled 125-280 solution that is used to supply the required dosage of hydrogen peroxide per cycle, as well as used in the sterilization process of the STERIZONE 125L+/VP4 sterilizer; double door STERIZONE sterilizer for use in the STERIZONE VP4 sterilizer; and the STERIZONE 80L sterilizer. Further, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.

Corporate Governance

TSO3 Inc.’s ISS Governance QualityScore as of October 4, 2017 is 8. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.